Dr. Robert Wadley responds to urine drug toxicology testing article

Robert Wadley, MD (Brier Creek Pain and Spine YouTube ad)

Robert Wadley, MD
(Brier Creek Pain and Spine YouTube ad)

A week ago today, I wrote a blog post that discussed a Wall Street Journal article about urine drug toxicology testing.

A large part of the WSJ article (and my post) focused on Dr. Robert Wadley, a pain physician in North Carolina who performs in-office urine drug toxicology testing and also owns a urine drug toxicology laboratory called AvuTox.

Dr. Wadley reached out with some comments about my post and the WSJ article earlier this morning, and in the interest of allowing both sides to present their side of the story, I would like to post his comments here.

Many thanks to Dr. Wadley for taking the time to help us understand his perspective.

What follows is Dr. Wadley’s complete and unedited comments.


To the writer of this blog,

It may be hard/impossible for you to comprehend facts. But to give you the benefit of the doubt, here is my response to the WSJ article. Note in it who made the recommendation that is being advanced by Palmetto, GBA that will save the Medicare trust fund $100’s of millions/year. It was not your precious Government nor a large reference lab, and it was not you.

I am R. Wadley, MD, the owner of BCIPS and AvuTox, and I would like to respond to this WSJ article.

To start with, the premise of the article is false. The author equated Medicare patients with the elderly. In a pain practice this notion is not true. This false premise implies that pain doctors are testing nursing home patients for illicit drugs purely to make money. The truth is Medicare also insures the disabled population and a subset of the disabled population are those suffering from chronic pain. In fact, my practice has a small fraction of what would be considered elderly. Rather, all of my Medicare patients have chronic pain for which we prescribe controlled substances. Our duty is not only to treat this pain but also to do our due diligence to ensure that the medications are being taken as we prescribe them. For this reason, yes I do and will, test all of my patients for prescribed and illicit medications.

[Continue reading]

Important update regarding CMS’ 2015 ancillary services packaging policy

Earlier this month I wrote an article that included a summary of the ancillary services packaging policy the Centers for Medicare and Medicaid Services (CMS) implemented in its 2015 Hospital Outpatient Prospective Payment/Ambulatory Surgical Center Payment Systems Final Rule. That summary stated CMS had: ...finalized its proposal to package the technical component of select ancillary services, including many anatomic pathology services, into a single unified payment for services provided … [Continue reading]

Florida laboratory kickback scheme results in two arrests

David Brock Lovelace, Vice President of Cornerstone Health Specialists, and Dale DuBois, managing member of Healthcare Marketing Florida LLC, were arrested last week and charged with conspiracy to defraud Medicare and paying illegal kickbacks for clinical laboratory testing referrals. Unfortunately, I do not know much more than what is available in this short Department of Justice press release, as the case is so new the complaint is not yet publicly available.  I will try to find out … [Continue reading]

Yup. All those urine drug tests are totally necessary, doctor.

Robert Wadley, MD
(Brier Creek Pain and Spine YouTube ad)

The Wall Street Journal recently published a great article that once again perfectly demonstrates why physician self-referral and urine drug toxicology testing are a dangerous combination. Doctors play Medicare "Whac-a-Mole" The article begins by discussing how physicians are testing the urine of senior citizens for drugs they rarely use, like cocaine, heroin, PCP (angel dust), etc, at "soaring rates", and how many pain doctors make more money from urine drug testing than they do treating … [Continue reading]

Laboratory analyzer manufacturers and reference laboratories panic over Ebola

Ebola virus (NBC News)

USA Today last week put out an interesting article that discussed the seemingly irrational fears some laboratories and makers of laboratory analyzers have about Ebola. With respect to lab analyzer manufacturers, this paragraph sums it up: Several leading manufacturers of high-tech diagnostic devices have alerted hospital laboratories that they will restrict service, support and warranties for equipment used to test blood and organ functions for Ebola patients. Fearing infections, some … [Continue reading]

$125,000 settlement reached against forensic pathologist Dr. Norman Thiersch

Snohomish County death investigator Deborah Hollis has reached a $125,000 settlement with county authorities in a lawsuit that accused Snohomish County Washington Medical Examiner Dr. Norman Thiersch of sexual discrimination, failure to accommodate her diabetes, retaliation, and splashing her with blood during autopsies.  In addition to the financial award, Ms. Hollis will keep her job at the Medical Examiner's office and will be sent to Texas for "forensics training". Ms. Hollis filed her … [Continue reading]

Pathology researcher sues anonymous PubPeer.com commenters for defamatory comments

Fazlul Sarkar, PhD (Cancer Therapy)

Fazlul Sarkar, PhD, has filed a lawsuit against anonymous commenters on the website PubPeer.com (the owners/webmasters of which are also anonymous), alleging comments submitted to the site about his research were false and defamatory and led to the loss of a job offer at the University of Mississippi and loss of tenure at Wayne State University. Facts/Allegations The complaint starts with a description of Dr. Sarkar's 35 year career as a pathology researcher, which, from all outward … [Continue reading]

OIG announces intent to scrutinize independent clinical laboratories in 2015

The Office of the Inspector General (OIG) for the Department of Health and Human Services has announced it plans to "review Medicare payments to independent clinical laboratories to determine laboratories’ compliance with selected billing requirements" in 2015. OIG made this announcement on page 16 of its "Work Plan for Fiscal Year 2015": Selected independent clinical laboratory billing requirements (new) We will review Medicare payments to independent clinical laboratories to determine … [Continue reading]

CMS releases 2015 OPPS/ASC and PFS/CLFS Final Rules

The Centers for Medicare and Medicaid Services (CMS) on Halloween night released the 2015 Final Rules for the Physician Fee/Clinical Laboratory Fee Schedules and the Hospital Outpatient Prospective Payment/Ambulatory Surgical Center Payment Systems. Obviously there is quite a bit in there, and for this initial article I will only hit the highlights. Packaging of Ancillary Services Probably the most significant aspect of these Final Rules is that CMS has finalized its proposal to package … [Continue reading]

Halloween costume tips for pathology types by Michael Farmer

I received an email earlier today from Mr. Michael Farmer, manager of McEvoy and Farmer, a market research firm that specializes in in-vitro diagnostics and anatomic pathology, about Halloween costumes. Mr. Farmer, whom I have never met in person, obviously has a well-exercised sense of humor, and he uses that sense of humor to write articles that are very light and easy to read yet contain insightful information on the current state of the pathology and lab medicine industry. As with … [Continue reading]

Palmetto GBA gives the College of American Pathologists the LCD it wanted

Palmetto GBA, the Medicare Administrative Contractor (MAC) for Jurisdiction 11 (the Carolinas and Virginias), has just released a very extensive draft local coverage determination (LCD) policy that addresses the overutilization of immunohistochemical (IHC) and special stains by pathologists for breast, gastrointestinal, prostate, lung, gynecologic, genitourinary, skin, soft tissue, central and peripheral nervous systems, bone marrow and tumor chemosensitivity specimens. It would appear the … [Continue reading]

Laboratory whistleblower Chris Riedel sued by different laboratory whistleblowers

A US district judge in New Jersey recently denied a motion to dismiss filed by laboratory whistleblower Chris Riedel of Hunter Laboratories in a lawsuit brought against him by laboratory whistleblowers Fair Laboratory Practices Associates (FLPA) and NPT Associates (NPT). I only just now came across the suit, which was originally filed in April 2014, but it is still interesting nonetheless and far from being resolved. The Parties FLPA and NPT are separate general partnerships formed in … [Continue reading]

21st Century Oncology in OIG crosshairs for urine FISH self-referral

(Wall Street Journal)

John Carreyrou of the Wall Street Journal published yet another excellent article about pathology self-referral last week that focuses on 21st Century Oncology and its urine fluorescence in-situ hybridization (FISH) referrals. Basically, the article provides yet another example (as if any more were necessary at this point) of how physicians exploit the in-office ancillary services exception to the Stark Law for their own personal financial gain. 21st Century was founded in 1983, but did … [Continue reading]

Appeals court reverses $1.5 million organ incineration award

A Florida appeals court has reversed the final judgment of a lower court that awarded $1.5 million to the daughter of a woman whose organs were incinerated after autopsy. I first wrote about this case on September 10, 2012, right after the original verdict was announced, and then again nine days later after a local news report raised some interesting questions about the case. Background Ms. Sharren Sutka died on March 27, 2005* at Winter Haven Hospital in Winter Haven Florida.  Her … [Continue reading]

Cigna sues Health Diagnostic Laboratory for fee-forgiving fraud

Health insurance provider Cigna has filed suit against Health Diagnostic Laboratory (HDL), alleging HDL unlawfully obtained at least $84 million from it through a "fraudulent fee-forgiving scheme". Readers will recall HDL is one of the laboratories being investigated by the Office of the Inspector General (OIG) for the Department of Health and Human Services for possibly paying kickbacks to physicians in exchange for referrals. Not soon after that fact came to light, the HDL CEO, Tonya … [Continue reading]